“Viral Vectors created from nano-robots or nano-diamonds are powerful tools for swapping incorrect genes”, says RNCOS.
Noida, UP -- (SBWIRE) -- 12/19/2014 -- According to a new research report by RNCOS entitled, "Global Gene Therapy Market Outlook 2018", nanotechnology is being increasingly incorporated in gene therapy to make gene transfer easier. Recently scientists at the University of Tokyo have built a nanocarrier being capable of light-mediated gene delivery into a solid cancerous tumor. The nanocarrier comprised of polyplex micelle - a self-assembling structure with three distinct layers. The micelle comprises a pDNA core, followed by an intermediary layer of dendrimeric photosensitizer (DPc), and finally an outer hydrophilic layer of poly (ethylene glycol) which forms a shield to protect the package during passage through the body.
Nanotechnology products such as nano-robots or nano-diamonds are small enough to enter the body and even used to redesign genome. Nanotechnology in gene therapy would be applied to replace the currently used viral vectors with the potentially less immunogenic nano-size gene carriers. Several non-viral vectors have been designed with the help of nano-particles. Hence, the delivery of repaired genes or the replacement of incorrect genes will be easily accomplished in the near future with the help of nanotechnology. Nanoparticles are being targeted against solid tumors without harming other cells or tissues.
The report is spread in over 120 pages and provides an in-depth research and rational analysis of the global gene therapy market. A brief overview of the key geographies in the gene therapy segment and the regulatory scenario governing the industry has also been included in the study to present a balanced outlook. The report covers how major trends and drivers, including nanotechnology, advanced therapies to treat chronic diseases etc will propel the industry's growth. With a view to understand the competitive landscape, the profiles of key market players are included in the report to present a complete picture of the global gene therapy market.
For FREE SAMPLE of this report visit:
Check Related REPORTS on:
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.